Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V7CD
|
|||
Former ID |
DNC008523
|
|||
Drug Name |
QNEQCPQVSac
|
|||
Synonyms |
CHEMBL506458
Click to Show/Hide
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C42H67N13O18S
|
|||
Canonical SMILES |
CC(C)C(C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NC(CS)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C
|
|||
InChI |
1S/C42H67N13O18S/c1-18(2)33(54-37(67)25(16-56)47-19(3)57)40(70)50-22(7-11-29(44)59)41(71)55-14-4-5-27(55)39(69)53-26(17-74)38(68)49-20(6-10-28(43)58)34(64)48-21(9-13-32(62)63)35(65)52-24(15-31(46)61)36(66)51-23(42(72)73)8-12-30(45)60/h18,20-27,33,56,74H,4-17H2,1-3H3,(H2,43,58)(H2,44,59)(H2,45,60)(H2,46,61)(H,47,57)(H,48,64)(H,49,68)(H,50,70)(H,51,66)(H,52,65)(H,53,69)(H,54,67)(H,62,63)(H,72,73)/t20-,21-,22-,23-,24-,25-,26-,27-,33-/m0/s1
|
|||
InChIKey |
GLSOSIFUCZBHCX-AYPRZOFJSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sodium/glucose cotransporter 1 (SGLT1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Carbohydrate digestion and absorption | |||
Bile secretion | ||||
Mineral absorption | ||||
Pathwhiz Pathway | Lactose Degradation | |||
Trehalose Degradation | ||||
Reactome | Hexose transport | |||
Na+-dependent glucose transporters | ||||
Inositol transporters | ||||
WikiPathways | NRF2 pathway | |||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
Metabolism of carbohydrates |
References | Top | |||
---|---|---|---|---|
REF 1 | Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity. J Biol Chem. 2007 Sep 28;282(39):28501-13. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.